UPSIDE Magazine and MIT's Technology Review Recognize Syrrx Excellence with Awards.Business Editors SAN DIEGO--(BUSINESS WIRE)--May 23, 2002 Syrrx Selected as UPSIDE Hot 100 Company; Syrrx Co-Founder Nathaniel David, Ph.D. Named to TR100 as One of World's Top Young Innovators Syrrx, Inc., a high-throughput rational drug discovery company, today announced it has been recognized for excellence and innovation among life science and technology companies nationwide by UPSIDE Magazine, which selected Syrrx as a 2002 Hot 100 Company. Independently, Technology Review, MIT's award-winning magazine of innovation, selected Syrrx co-founder Nathaniel David, Ph.D., as one of the world's 100 Top Young Innovators. Syrrx is being recognized by UPSIDE for the company's achievement in developing novel, proprietary high-throughput drug discovery technologies, raising nearly $100 million since its founding, and sealing collaborations with industry leaders including Hoffman-La Roche, Pharmacia, Cubist Pharmaceuticals and Celera Genomics. UPSIDE will publish the Hot 100 Award winners in its June 2002 issue and online at UPSIDE.com. "We evaluated hundreds of great companies that spanned a broad range of technology market segments, and we are pleased to recognize Syrrx as one of this year's winners," said Jerry Borrell, editor-in-chief of UPSIDE Magazine. "This award has consistently recognized companies that have become the hallmark of excellence in technology and achieved successful IPOs or merged with other companies. We expect big things from this year's winners and look forward to following Syrrx's success." Dr. David was David Was (born David Weiss, 26 October 1952, Detroit) is, with his stage-brother Don Was, the founder of the influential 1980s pop group, Was (Not Was). Reviewed by The New York Times among 100 individuals under the age of 35 honored by Technology Review for work in business and technology that has had a profound impact on today's world. Dr. David was named to Technology Review's 2002 TR100 for his contribution in transforming the nature of the biotechnology industry and drug discovery through technological innovation. He is being honored today at the TR100 conference and awards ceremony at the Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, . "The TR100 distinction is a great honor, but to be perfectly honest, Syrrx's success has been a total team effort," said Dr. David. "When I look around at the Syrrx team, I am impressed by the number of talented, brilliant people I get to work with each day." Dr. David's work in biology, biochemistry and technology contributed significantly to the deployment of Syrrx's automated structure-based drug discovery technologies, which reduce the time and cost associated with drug discovery. As the founding employee of Syrrx, Dr. David played a key role in the development of the Syrrx "gene to drug" platform -- a series of novel, proprietary tools that use high-throughput automation to bypass historical bottlenecks in the classical protein structure determination process, resulting in highly reliable and economical determination of protein structures. Syrrx scientists use this structural information as they seek to discover drugs that address unmet medical needs. Dr. David received his A.B. in Biology and Biochemistry from Harvard University Harvard University, mainly at Cambridge, Mass., including Harvard College, the oldest American college. Harvard College Harvard College, originally for men, was founded in 1636 with a grant from the General Court of the Massachusetts Bay Colony. (1990) and his Ph.D. in Molecular and Cellular Biology cellular biology n. The study of the molecular or chemical interactions of biological phenomena. from the University of California, Berkeley The University of California, Berkeley is a public research university located in Berkeley, California, United States. Commonly referred to as UC Berkeley, Berkeley and Cal (1998). As one of the earliest employees of Cell Genesys, Inc., Dr. David was one of the genetic engineers responsible for developing the Xenomouse, a transgenic animal Transgenic animal Animals that have had genes from other species inserted into their genetic code. Mentioned in: Glycogen Storage Diseases now marketed by Abgenix, Inc. During his doctoral work, Dr. David developed novel methods for the production, purification, and crystallization Crystallization The formation of a solid from a solution, melt, vapor, or a different solid phase. Crystallization from solution is an important industrial operation because of the large number of materials marketed as crystalline particles. of cell-surface receptors. Aspects of this technology are currently in use at Syrrx as part of an effort to determine the 3D shapes of cell surface receptors. About UPSIDE Magazine's Hot 100 Award The 2002 UPSIDE Hot 100 were selected by a team of UPSIDE editors, venture capitalists, financial analysts, market researchers and other industry luminaries who evaluated more than 400 nominations. The UPSIDE Hot 100 Award is judged on a company's technological achievements, customer acceptance of products or services, financial performance, industry partnerships, financial backing, management savvy and marketing. About Technology Review Inc. Technology Review, MIT's magazine of Innovation, is the world's oldest technology magazine. The magazine, as well as its signature events and Internet businesses, delivers essential information on emerging technologies on the verge On the Verge (or The Geography of Yearning) is a play written by Eric Overmyer. It makes extensive use of esoteric language and pop culture references from the late nineteenth century to 1955. of commercialization. Since 1998, Technology Review's paid circulation has more than tripled, from 92,000 to 310,000 (as of January 2002). Several hundred thousand current MIT MIT - Massachusetts Institute of Technology alumni, faculty and students, senior technology thinkers and influencers -- venture capitalists, chief scientists, researchers, senior corporate executives, investors, and innovators throughout the world -- constitute the Technology Review community. The TR100 event, themed "The Innovation Economy: How Technology is Transforming Existing Businesses and Creating New Ones," includes a full day of conference sessions and panel discussions followed by an evening awards ceremony. Hosted by Technology Review's Editor-in-Chief John Benditt and CNBC's Consuelo Mack, conference speakers include international leaders such as Kenneth Starr
Kenneth Winston Starr (born July 21, 1946) is an American lawyer and former judge who was appointed to the Office of the Independent Counsel to investigate the death of the , Esq.; Clayton Christensen, Harvard Business School Harvard Business School, officially named the Harvard Business School: George F. Baker Foundation, and also known as HBS, is one of the graduate schools of Harvard University. professor and author of The Innovators Dilemma; Nadine Strossen Nadine Strossen (born August 18, 1950) is the current president of the American Civil Liberties Union. She is the first woman and the youngest person to ever lead the ACLU. A professor at New York Law School, Professor Strossen also sits on the Council on Foreign Relations. , president of the ACLU ACLU: see American Civil Liberties Union. ; Rodney Brooks Rodney Allen Brooks (b. December 30, 1954 in Adelaide, Australia) is Panasonic Professor of Robotics at the Massachusetts Institute of Technology. He is Chief Technical Officer and sits on the Board of iRobot Corp. , Director of the Artificial Intelligence Laboratory and Co-director of Project Oxygen, MIT; Richard Rashid Richard 'Rick' Rashid currently oversees Microsoft Research's worldwide operations. Previously, he was the director of Microsoft Research. He joined Microsoft Research in 1991, and was promoted to vice president in 1994. In 2000, he became senior vice president. , Senior Vice President, Microsoft Research Microsoft Research (MSR) is a division of Microsoft created in 1991 for researching various computer science topics and issues. Overview Microsoft Research (MSR) is one of the top research centers worldwide, currently employing Turing Award winners, C.A.R. ; and David Tennenhouse, Vice President and Corporate Technology Group Director, Intel Corporation. About Syrrx, Inc. Syrrx, Inc. is a drug discovery company committed to redefining the way medicines are discovered. Based in San Diego, CA, the company is at the forefront of high-throughput rational drug discovery. Syrrx intends to leverage high-throughput structure determination, high-throughput screening, combinatorial and medicinal chemistry together with computational methods to discover novel small molecule preclinical drug candidates. This process enables a unique "gene to drug" platform based on the ability to perform high-throughput rational drug discovery. Syrrx has structural proteomic and drug discovery collaborations with industry leaders, including Hoffman La-Roche Ltd., Pharmacia Corporation, Celera Genomics, and Cubist Pharmaceuticals. The company has also acquired small molecule assets from Onyx Pharmaceuticals for use in the internal discovery programs at Syrrx. For more information, please visit the Syrrx website at http://www.syrrx.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion